Commence Secures Position on $3.5B CMS RMADA 3 IDIQ, Expanding Its Role in Federal Health Policy Research and Model Evaluation

Commence Secures Position on $3.5B CMS RMADA 3 IDIQ, Expanding Its Role in Federal Health Policy Research and Model Evaluation

Commence has been awarded a prime contractor position on the Centers for Medicare & Medicaid Services (CMS) Research, Measurement, Assessment, Design, and Analysis (RMADA) 3 indefinite-delivery, indefinite-quantity (IDIQ) vehicle.

RMADA is CMS's primary contract vehicle for the analytic and operational work behind its innovation agenda. The contract supports the full lifecycle of model work, from design and implementation through data analysis, monitoring, and rapid-cycle evaluation. The award comes as CMS pursues a long-term transformation of the U.S. healthcare system, one that delivers higher-quality, more affordable, and more accessible care through evidence-based payment and service delivery models. Central to that agenda is the advance of value-based care: testing innovative payment and care delivery models designed to improve health outcomes, reduce the cost of care, and scale value-based payment and service delivery across Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).

Commence has supported CMS for over two decades in its mission to protect and empower beneficiaries, ensure appropriate coverage, and safeguard the integrity of its programs. The company combines deep health domain expertise with AI-native solutions that help CMS teams detect quality of care risks earlier, move program integrity upstream from detection to prevention, and make evidence-based model decisions with confidence.